Detecting False rRT-PCR COVID-19 Test Reports using Deep Learning Algorithms

Autor: Muhammad Naveed Younis, Ali Raza, Syed Hashim Raza Bukhari

Publikováno v: IEEE Technology Policy and Ethics. 6:1-5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d4e03c627e5301229adc6e08a15d3be1
https://doi.org/10.1109/ntpe.2021.9778157

The role of insulin detemir in overweight type 2 diabetes management

Autor: Yared N Demssie, Naveed Younis, Handrean Soran

Publikováno v: Vascular Health and Risk Management, Vol 2009, Iss default, Pp 553-560 (2009)

Yared N Demssie1, Naveed Younis2, Handrean Soran31Department of Diabetes and Endocrinology, Salford Royal Foundation NHS Trust, Salford, UK; 2Department of Medicine, University Hospital South Manchester Foundation NHS Trust, Wythenshawe, Manchester,

Externí odkaz: https://doaj.org/article/16cb961ab90a4831a38df2a1a6b71e3f

A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial

Autor: Safwaan Adam, Paul N. Durrington, See Kwok, J. Martin Gibson, Tarza Siahmansur, Handrean Soran, Martin K. Rutter, Jan H. Ho, Naveed Younis, Matthew Gittins, Jonathan Schofield, Yifen Liu

Publikováno v: Soran, H, Liu, Y, Adam, S, Siahmansur, T, Ho, J H, Schofield, J D, Kwok, S, Gittins, M, France, M, Younis, N, Gibson, J M, Durrington, P N & Rutter, M K 2017, ' A comparison of the effects of low-and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes : Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial ', Journal of Clinical Lipidology . https://doi.org/10.1016/j.jacl.2017.10.011

Background: Statin therapy is recommended in type 2 diabetes (T2DM) although views on treatment intensity and therapeutic targets remain divided. Objectives: Our objectives were to compare the effects of high-intensity and moderate-intensity atorvast

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a73c26fe257f8141eb5c902ce011fdde
https://pubmed.ncbi.nlm.nih.gov/29246729

Vildagliptin in clinical practice: a review of literature

Autor: Handrean Soran, Moulinath Banerjee, Naveed Younis

Publikováno v: Expert Opinion on Pharmacotherapy. 10:2745-2757

Vildagliptin is the second member of the DPP-IV inhibitor class of drugs licensed for the treatment of type 2 diabetes mellitus (T2DM). The novel action of these drugs has promoted a new outlook in the pathobiology of T2DM. This review undertakes to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ae67ea1d3c0e9461b17f8d7bdbfac9
https://doi.org/10.1517/14656560903302265

The role of the renin angiotensin system blocking in the management of atrial fibrillation

Autor: Handrean Soran, Naveed Younis, Merwen Al-Najjar, Hisham Ziglam

Publikováno v: Acta Cardiologica. 63:457-465

Objective - The objective of the study was to review the current available clinical evidence for the role of renin-agiotensin system (RAS) blockade in the treatment of atrial fibrillation (AF). Method - We conducted a pubmed and medline literature se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c86681d1f07a55f65b5e97c291a3b67
https://doi.org/10.2143/ac.63.4.2033044